Skip to main content
Journal of Psychiatry & Neuroscience : JPN logoLink to Journal of Psychiatry & Neuroscience : JPN
letter
. 2001 May;26(3):252–253.

Bipolar disorder after mefloquine treatment.

C Even, S Friedman, K Lanouar
PMCID: PMC1408302  PMID: 11394195

Full text

PDF
252

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Croft A. M., World M. J. Neuropsychiatric reactions with mefloquine chemoprophylaxis. Lancet. 1996 Feb 3;347(8997):326–326. doi: 10.1016/s0140-6736(96)90500-0. [DOI] [PubMed] [Google Scholar]
  2. Hollister L. E., Trevino E. S. Calcium channel blockers in psychiatric disorders: a review of the literature. Can J Psychiatry. 1999 Sep;44(7):658–664. doi: 10.1177/070674379904400702. [DOI] [PubMed] [Google Scholar]
  3. Steffen R. Travel medicine--prevention based on epidemiological data. Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):156–162. doi: 10.1016/0035-9203(91)90005-j. [DOI] [PubMed] [Google Scholar]
  4. Stürchler D., Handschin J., Kaiser D., Kerr L., Mittelholzer M. L., Reber R., Fernex M. Neuropsychiatric side effects of mefloquine. N Engl J Med. 1990 Jun 14;322(24):1752–1753. doi: 10.1056/nejm199006143222416. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Psychiatry and Neuroscience are provided here courtesy of Canadian Medical Association

RESOURCES